Yoram Bibring - Net Worth and Insider Trading

Yoram Bibring Net Worth

The estimated net worth of Yoram Bibring is at least $9,291 dollars as of 2024-12-28. Yoram Bibring is the CFO of Brainstorm Cell Therapeutics Inc and owns about 3,333 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $8,166. Yoram Bibring is also the Cheif Financial Officer of Marpai Inc and owns about 1,250 shares of Marpai Inc (MRAI) stock worth over $1,125. Details can be seen in Yoram Bibring's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yoram Bibring has not made any transactions after 2021-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Yoram Bibring

To

Yoram Bibring Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yoram Bibring owns 3 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , Healthcare Corporation of America (HCCA) , and Marpai Inc (MRAI) .

Click here to see the complete history of Yoram Bibring’s form 4 insider trades.

Insider Ownership Summary of Yoram Bibring

Ticker Comapny Transaction Date Type of Owner
BCLI Brainstorm Cell Therapeutics Inc 2015-08-20 Chief Financial Officer
HCCA Healthcare Corporation of America 2013-06-03 Chief Financial Officer
MRAI Marpai Inc 2021-12-15 Chief Financial Officer

Yoram Bibring Latest Holdings Summary

Yoram Bibring currently owns a total of 2 stocks. Among these stocks, Yoram Bibring owns 3,333 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of August 20, 2015, with a value of $8,166 and a weighting of 87.89%. Yoram Bibring also owns 1,250 shares of Marpai Inc (MRAI) as of December 15, 2021, with a value of $1,125 and a weighting of 12.11%.

Latest Holdings of Yoram Bibring

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCLI Brainstorm Cell Therapeutics Inc 2015-08-20 3,333 2.45 8,166
MRAI Marpai Inc 2021-12-15 1,250 0.90 1,125

Holding Weightings of Yoram Bibring


Yoram Bibring Form 4 Trading Tracker

According to the SEC Form 4 filings, Yoram Bibring has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 567 shares on August 20, 2015, which cost Yoram Bibring around $25,840.

According to the SEC Form 4 filings, Yoram Bibring has made a total of 1 transactions in Marpai Inc (MRAI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Marpai Inc is the acquisition of 1,250 shares on December 15, 2021, which cost Yoram Bibring around $21,650.

Insider Trading History of Yoram Bibring

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yoram Bibring Trading Performance

GuruFocus tracks the stock performance after each of Yoram Bibring's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yoram Bibring is -27.76%. GuruFocus also compares Yoram Bibring's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yoram Bibring within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yoram Bibring's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yoram Bibring

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.34 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.96 LIMIT LIMIT LIMIT LIMIT LIMIT

Yoram Bibring Ownership Network

Ownership Network List of Yoram Bibring

No Data

Ownership Network Relation of Yoram Bibring

Insider Network Chart

Yoram Bibring Owned Company Details

What does Brainstorm Cell Therapeutics Inc do?

Who are the key executives at Brainstorm Cell Therapeutics Inc?

Yoram Bibring is the Chief Financial Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .

Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary

Over the past 18 months, Yoram Bibring made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .

In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.

Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Brainstorm Cell Therapeutics Inc Insider Transactions

No Available Data

Yoram Bibring Mailing Address

Above is the net worth, insider trading, and ownership report for Yoram Bibring. You might contact Yoram Bibring via mailing address: C/o Selway Acquisition Corporation, 66 Ford Road, Suite 230, Denville Nj 07834.

Discussions on Yoram Bibring

No discussions yet.